IGF1 and myocardial infarction: Studies have demonstrated that the intramyocardial injection of the combination of adipocyte-derived stem cells (ADSC) with fibronectin (FN)-coated microcarriers delivering IGF and HGF injected in a 2-week-old MI model allowed an increase in vascularization of the infarcted area after 2 weeks of treatment.